Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosis of Monoclonal Gammopathy of Renal Significance in Patients With Paraproteinemias

NCT03629561 is registered in ClinicalTrials.gov with Academia Nacional de Medicina as lead sponsor.

NCT NCT03629561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosis of Monoclonal Gammopathy of Renal Significance in Patients With Paraproteinemias
Lead sponsor
Academia Nacional de Medicina
Phase
Observational
Overall status
Unknown status
Start date
February 23, 2019
Completion date
February 28, 2021
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy of renal significance